NucleoSpin® Plasma XS - MACHEREY
Contents
1. continue rinsing BEI KONTAKT MIT DEN AUGEN Einige Minuten lang behutsam mit Wasser sp len Vorhandene Kontaktlinsen nach M glichkeit entfernen Weiter sp len Call a POISON CENTER doctor if you feel unwell Bei Unwohlsein GIFTINFORMATIONSZENTRUM Arzt anrufen Rinse mouth Mund aussp len If skin irritation occurs Get medical advice attention Bei Hautreizung Arztlichen Rat einholen rztliche Hilfe hinzuziehen Get medical advice attention Bei anhaltende Augenreizung Arztlichen Rat einholen rztliche Hilfe hinzuziehen If experiencing respiratory symptoms Call a POISON CENTER doctor Bei Symptomen der Atemwege GIFTINFORMATIONSZENTRUM Arzt anrufen Wash contaminated clothing before reuse Kontaminierte Kleidung vor erneutem Tragen waschen Store in a well ventilated place Keep container tightly closed Beh lter dicht verschlossen an einem gut bel fteten Ort aufbewahren Store in a well ventilated place Keep cool K hl an einem gut bel fteten Ort aufbewahren MACHEREY NAGEL 06 2014 Rev 04 13 NucleoSpin Plasma XS 5 Protocols Before starting the preparation 5 1 Equilibrate sample to room temperature 18 25 C and make sure that the sample is cleared from residual cells cell debris and particular matter e g by centrifugation of the plasma sample for 3 min at 211 000 x g For the High Sensitivity procedure Set the thermal heating block to 75 90 C2. Circulating DNA from plasma User manual NucleoSpin Plasma XS June 2014 Rev 04 MACHEREY NAGEL www mn net com Circulating DNA from plasma Protocol at a glance Rev 04 NucleoSpin Plasma XS 1 Prepare sample High Sensitivity protocol Use up to 240 uL plasma Rapid protocol Use up to 200 uL plasma 1a Optional Proteinase K Add 20 uL Proteinase K Mix Incubate at 37 C for 10 min 2 Adjust binding conditions gt U gt treatment y gt Add 360 uL BB Add 300 uL BB 3 Mix sample Invert tube 3x Vortex 3s Spin down briefly Invert tube 3x Vortex 3s Spin down briefly 4 Bind DNA Load lysate Load Iysate 2 000 x g 11 000 x g 30s 30s 11 000 x g 5s 5 Wash and dry 1S wash 500 pL WB 1 wash 500 pL WB silica mem 11 000 x g 11 000 x g brane 30s 30s 2 wash 250 uL WB 2rd wash 250 uL WB 11 000 x g 11 000 x g 3 min 3 min 6 Elute DNA 20 uL Elution Buffer 20 uL Elution Buffer es 11 000 x g 11 000 x g 30s 30s 7 Removal of re sidual ethanol 90 C j 8 min MACHEREY NAGEL GmbH amp Co KG Neumann Neander Str 6 8 52355 D ren Germany Tel 49 24 21 969 270 Fax 49 24 21 969 199 tech bio mn net com www mn net com Circulating DNA from plasma Table of contents 1 Components 1 1 Kit contents 1 2 Consumables and equipment to be supplied by user 1 3 About this user manual 2 Product descri
3. Biol 2006 336 111 21 Chan KC Yeung SW Lui WB Rainer TH Lo YM Effects of preanalytical factors on the molecular size of cell free DNA in blood Clin Chem 2005 Apr 51 4 781 4 Epub 2005 Feb 11 Chan KC Zhang J Chan AT Lei KI Leung SF Chan LY Chow KC Lo YM Molecular characterization of circulating EBV DNA in the plasma of nasopharyngeal carcinoma and lymphoma patients Cancer Res 2003 May 1 63 9 2028 32 Chan KC Zhang J Hui AB Wong N Lau TK Leung TN Lo KW Huang DW Lo YM Size distributions of maternal and fetal DNA in maternal plasma Clin Chem 2004 Jan 50 1 88 92 Chiu RW Lo YM Noninvasive prenatal diagnosis by analysis of fetal DNA in maternal plasma Methods Mol Biol 2006 336 101 9 Chiu TW Young R Chan LY Burd A Lo DY Plasma cell free DNA as an indicator of severity of injury in burn patients Clin Chem Lab Med 2006 44 1 13 7 Chun FK Muller I Lange Friedrich MG Erbersdobler A Karakiewicz PI Graefen M Pantel K Huland H Schwarzenbach H Circulating tumour associated plasma DNA represents an independent and informative predictor of prostate cancer BJU Int 2006 Sep 98 3 544 8 Deligezer U Erten N Akisik EE Dalay N Circulating fragmented nucleosomal DNA and caspase 3 mRNA in patients with Iymphoma and myeloma Exp Mol Pathol 2006 Feb 80 1 72 6 Epub 2005 Jun 15 Fatouros IG Destouni A Margonis K Jamurtas AZ Vrettou C Kouretas D Mastorakos G Mitrakou A Taxildaris K Kanavakis
4. E Papassotiriou Cell free plasma DNA as a novel marker of aseptic inflammation severity related to exercise overtraining Clin Chem 2006 Sep 52 9 1820 4 Epub 2006 Jul 13 Giacona MB Ruben GC Iczkowski KA Roos TB Porter DM Sorenson GD Cell free DNA in human blood plasma length measurements in patients with pancreatic cancer and healthy controls Pancreas 1998 Jul 17 1 89 97 Hanley R Rieger Christ KM Canes D Emara NR Shuber AP Boynton KA Libertino JA Summerhayes IC DNA integrity assay a plasma based screening tool for the detection of prostate cancer Clin Cancer Res 2006 Aug 1 12 15 4569 74 Hromadnikova Zejskova L Doucha J Codl D Quantification of fetal and total circulatory DNA in maternal plasma samples before and after size fractionation by agarose gel electrophoresis DNA Cell Biol 2006 Nov 25 11 635 40 Jiang WW Zahurak M Goldenberg D Milman Y Park HL Westra WH Koch W Sidransky D Califano J Increased plasma DNA integrity index in head and neck cancer patients Int J Cancer 2006 Dec 1 119 11 2673 6 MACHEREY NAGEL 06 2014 Rev 04 21 Circulating DNA from plasma Jung M Klotzek S Lewandowski M Fleischhacker M Jung K Changes in concentration of DNA in serum and plasma during storage of blood samples Clin Chem 2003 Jun 49 6 Pt 1 1028 9 Koide K Sekizawa A Iwasaki M Matsuoka R Honma S Farina A Saito H Okai T Fragmentation of cell free fetal DNA in plasma and urine of p
5. effects Sch dlich f r Wasserorganismen mit langfristiger Wirkung Contact with acids liberates toxic gas Entwickelt bei Ber hrung mit S ure giftige Gase Precaution phrases P 210 P 233 P 260D P 261 P 273 P 280 P 301 312 P 302 352 P 304 340 P 305 351 338 P 312 P 330 P 332 313 P 337 313 P 342 311 P 363 P 403 233 P 403 235 Keep away from heat sparks open flames hot surfaces No smoking Von Hitze Funken offener Flamme hei en Oberfl chen fernhalten Nicht rauchen Keep container tightly closed Beh lter dicht verschlossen halten Do not breathe vapours Dampf nichht einatmen Avoid breathing dust Einatmen von Staub vermeiden Avoid release to the environment Freisetzung in die Umwelt vermeiden Wear protective gloves eye protection Schutzhandschuhe Augenschutz tragen IF SWALLOWED Call a POISON CENTER doctor if you feel unwell BEI VERSCHLUCKEN Bei Unwohlsein GIFTINFORMATIONSZENTRUM Arzt anrufen IF ON SKIN Wash with plenty of water BEI KONTAKT MIT DER HAUT Mit viel Wasser waschen IF INHALED If breathing is difficult remove to fresh air and keep at rest ina position comfortable for breathing BEI EIANTMEN Bei Atembeschwerden an die frische Luft bringen und in einer Position ruhigstellen die das Atmen erleichtert IF IN EYES Rinse continuously with water for several minutes Remove contact lenses if present and easy to do
6. for final ethanol removal see section 2 6 for details High sensitivity protocol for the isolation of DNA from plasma Prepare sample Add 240 uL plasma to a microcentrifuge tube not provided Less than 240 uL may be used Adopt the binding buffer volume accordingly see below 1a Optional Proteinase K treatment Add 20 uL Proteinase K to the plasma sample mix and incubate at 37 C for 10 min Depending on the plasma sample and the PCR conditions the proteinase treatment of the plasma sample provokes a increase of the PCR signal of 0 5 1 5 cycles i e the cycle threshold Ct value crossing point Cp value is reached 0 5 1 5 cycles earlier The proteinase treatment may however alter the ratio of high to low molecular weight DNA Adjust DNA binding conditions Add 360 uL Buffer BB If less than 240 uL plasma is used adjust the binding buffer volume accordingly A ratio of 1 1 5 v v for plasma and binding buffer has to be ensured Mix sample Invert the tube 3x and vortex for 3 s Centrifuge the tube briefly to clean the lid y am 240 uL plasma Optional 20 uL Proteinase K 360 pL BB Mix sample 14 MACHEREY NAGEL 06 2014 Rev 04 NucleoSpin Plasma XS Bind DNA For each sample load the mixture 720 uL to a NucleoSpin Plasma XS Column placed in a Collection Tube 2 mL Centrifuge at 2 000 x g for 30 s increase centrifuge force to 11 000 x
7. g for further 5 s Discard Collection Tube with flow through and place column into new Collection Tube provided The maximal column volume is approximately 600 uL Do not apply a higher volume in order to avoid spillage If larger plasma sample volumes have to be processed the loading step may be repeated Be aware of an increased risk of membrane clogging in case of multiple column loading steps If the solution has not completely passed the column centrifuge for an additional 60 s at 11 000 xg Wash and dry silica membrane Pipette 500 uL Buffer WB onto the NucleoSpin Plasma XS Column Centrifuge for 30s at 11 000 x g Discard Collection Tube with flow through and place the column into new Collection Tube provided Add 250 pL Buffer WB to the NucleoSpin Plasma XS Column Centrifuge for 3 min at 11 000 x g Discard Collection Tube with flow through and place the column into a 1 5mL microcentrifuge tube for elution not provided Elute DNA Add 20 uL Elution Buffer to the NucleoSpin Plasma XS Column Centrifuge for 30 s at 11 000 x g Elution volume may be varied in range of 5 30 uL For a correlation of elution volume DNA concentration and DNA amount eluted from the column see section 2 4 Load lysate 2 000 x g 30s 11 000 x g 5s 500 pL WB 11 000 x g 30s 250 pL WB 11 000 x g 3 min 20 pL Elution Buffer 11 000 x g 30s MACHEREY NAGEL 06 2014 Rev 04 15 N
8. may be influenced by minor amounts of silica quantification abrasion In order to prevent incorrect A quantification values of small DNA amounts centrifuge the eluate for 30 s at gt 11 000 x g and take an aliquot for measurement without disturbing any sediment Alternatively use a silica abrasion insensitive DNA quantification method e g PicoGreen fluorecent dye Measurement not in the range of photometer detection limit In order to obtain a significant A A ratio it is necessary Unexpected that the initially measured A p and A values are A250 Ago ratio significantly above the detection limit of the photometer used An A value close to the background noise of the photometer will cause unexpeced A A ratios 6 2 Ordering information Product REF Pack of NucleoSpin Plasma XS 740900 10 50 250 10 50 250 Buffer BB 740394 22 22 mL Buffer WB 740331 250 mL Collection Tubes 2 mL 740600 1000 6 3 References Birch L English CA O Donoghue K Barigye O Fisk NM Keer JT Accurate and robust quantification of circulating fetal and total DNA in maternal plasma from 5 to 41 weeks of gestation Clin Chem 2005 Feb 51 2 312 20 Epub 2004 Dec 17 20 MACHEREY NAGEL 06 2014 Rev 04 Circulating DNA from plasma Chan KC Lo YM Clinical applications of plasma Epstein Barr virus DNA analysis and protocols for the quantitative analysis of the size of circulating Epstein Barr virus DNA Methods Mol
9. robustness of the PCR system 40 template volume were tested using LightCycler PCR Roche with DyNAmo Capillary SYBR Green qPCR Kit Finnzymes MACHEREY NAGEL 06 2014 Rev 04 9 Circulating DNA from plasma 25 without shaking A 700 rpm 1400 rpm N e a Incubation time min 3 65 70 75 80 85 90 95 Incubation temperature C Figure 2 Removal of residual ethanol from the elution fraction by heat treatment In order to obtain highest PCR sensitivity heat incubation of the eluate is recommended Heat incubation may be performed at temperatures of 70 90 C in a heat block with or without shaking Effective conditions temperature time and shaking rate for ethanol removal can be read from the diagram an initial volume of 20 uL will evaporate to 12 14 uL during the described incubation 2 6 Stability of isolated DNA Due to the typically low DNA content in plasma and the resulting low total amount of isolated DNA its fragmentation and the absence of DNase inhibitors the elution buffer does NOT contain EDTA the eluates should be placed on ice for short term and frozen at 20 C for long term storage 10 MACHEREY NAGEL 06 2014 Rev 04 Circulating DNA from plasma 3 Storage conditions and preparation of working solutions Attention The Buffer BB contains chaotropic salt and ethanol Wear gloves and goggles CAUTION Buffer BB cont
10. AGEL product leaflets MACHEREY NAGEL products are intended for GENERAL LABORATORY USE ONLY MACHEREY NAGEL products are suited for QUALIFIED PERSONNEL ONLY MACHEREY NAGEL products shall in any event only be used wearing adequate PROTECTIVE CLOTHING For detailed information please refer to the respective Material Safety Data Sheet of the product MACHEREY NAGEL products shall exclusively be used in an ADEQUATE TEST ENVIRONMENT MACHEREY NAGEL does not assume any responsibility for damages due to improper application of our products in other fields of application Application on the human body is STRICTLY FORBIDDEN The respective user is liable for any and all damages resulting from such application DNA RNA PROTEIN purification products of MACHEREY NAGEL are suitable for N VITRO USES ONLY ONLY MACHEREY NAGEL products specially labeled as IVD are also suitable for IN VITRO diagnostic use Please pay attention to the package of the product IN VITRO diagnostic products are expressly marked as IVD on the packaging IF THERE IS NO IVD SIGN THE PRODUCT SHALL NOT BE SUITABLE FOR IN VITRO DIAGNOSTIC USE ALL OTHER PRODUCTS NOT LABELED AS IVD ARE NOT SUITED FOR ANY CLINICAL USE INCLUDING BUT NOT LIMITED TO DIAGNOSTIC THERAPEUTIC AND OR PROGNOSTIC USE No claim or representations is intended for its use to identify any specific organism or for clinical use included but not limited to diagnostic prognostic therapeutic or blood banki
11. Y NAGEL makes no other warranty of any kind whatsoever and SPECIFICALLY DISCLAIMS AND EXCLUDES ALL OTHER WARRANTIES OF ANY KIND OR NATURE WHATSOEVER DIRECTLY OR INDIRECTLY EXPRESS OR IMPLIED INCLUDING WITHOUT LIMITATION AS TO THE SUITABILITY REPRODUCTIVITY DURABILITY FITNESS FOR A PARTICULAR PURPOSE OR USE MERCHANTABILITY CONDITION OR ANY OTHER MATTER WITH RESPECT TO MACHEREY NAGEL PRODUCTS In no event shall MACHEREY NAGEL be liable for claims for any other damages whether direct indirect incidental compensatory foreseeable consequential or special including but not limited to loss of use revenue or profit whether based upon warranty contract tort including negligence or strict liability arising in connection with the sale or the failure of MACHEREY NAGEL products to perform in accordance with the stated specifications This warranty is exclusive and MACHEREY NAGEL makes no other warranty expressed or implied The warranty provided herein and the data specifications and descriptions of this MACHEREY NAGEL product appearing in MACHEREY NAGEL published catalogues and product literature are MACHEREY NAGEL s sole representations concerning the product and warranty No other statements or representations written or oral by MACHEREY NAGEL s employees agent or representatives except written statements signed by a duly authorized officer of MACHEREY NAGEL are authorized they should not be relied upon by the customer and ar
12. ains guanidinium thiocyanate which can form highly reactive compounds when combined with bleach sodium hypochlorite DO NOT add bleach or acidic solutions directly to the sample preparation waste Storage conditions All kit components can be stored at room temperature 18 25 C and are stable for at least one year If there is any precipitate present in the buffers warm the buffer up to 25 37 C to dissolve the precipitate before use Before starting any NucleoSpin Plasma XS protocol prepare the following Before first use of the kit add the indicated volume of Proteinase Buffer PB to dissolve Iyophilized Proteinase K see bottle or table below Proteinase K solution is stable at 20 C for at least 6 months NucleoSpin Plasma XS 10 preps 50 preps 250 preps REF 740900 10 740900 50 740900 250 Proteinase K 6 mg 30 mg 2x75 mg lyophilized Add 260 uL Add 1 35 mL Add 3 35 mL Proteinase Buffer Proteinase Buffer Proteinase Buffer to each vial MACHEREY NAGEL 06 2014 Rev 04 11 Circulating DNA from plasma 4 Safety instructions The following components of the NucleoSpin Plasma XS kits contain hazardous contents Wear gloves and goggles and follow the safety instructions given in this section GHS classification Only harmful features do not need to be labeled with H and P phrases up to 125 mL or 125 g Mindergef hrliche Eigenschaften m ssen bis 125 mL oder 125 g nicht mit H und P S tzen gekenn
13. e not a part of the contract of sale or of this warranty Product claims are subject to change Therefore please contact our Technical Service F fki Shepp to date information on MACHEREY NAGEL products You may also Contac your local distributor for general scientific information Applications PAREHA RAEM EecReee Pfiterature are provided for informational purposes bight OVERS is eREdeNats eta qeeebaoeliae Bethe Steep applications have been tested in NP N RAT METER iit MACHEREY NASEL products MACHEREY Riagstegeadea FOISIRAP Ket e edi rd Maltese at BINh OF tHGse applications SYBR is a registered trademark of Molecular Probes Inc KRst update Ma a DiPatlBAY c9 be brands trademarks or registered labels of their respective i dhey are not special denotation To mention products and brands is only a kind of i Oni t n inst trademarks and brands and can not be seen as a kind M NANen Eo Hrica these products or services we can not grant any guarantees regarding selection efficiency or operation 24 MACHEREY NAGEL 06 2014 Rev 04 Circulating DNA from plasma Tel 49 24 21 969 270 e mail tech bio mn net com MACHEREY NAGEL 06 2014 Rev 04 25
14. ezer et al 2006 Giacona et al 1998 Hanley et al 2006 Hromadnikova et al 2006 Jiang et al 2006 Koide et al 2005 Li et al 2006 2005 2004 Wang et al 2004 According to this the NucleoSpin Plasma XS purification system is designed for the efficient isolation of highly fragmented DNA in a range of 50 1000 bp Within this range fragments are recovered with similar high efficiency MACHEREY NAGEL 06 2014 Rev 04 7 Circulating DNA from plasma 2 3 Handling of sample material Several publications indicate strong influence of blood sampling handling storage and plasma preparation on DNA yield and DNA quality Page et al 2006 Sozzi et al 2005 Chan et al 2005 Lam et al 2004 Jung et al 2003 Therefore it is highly recommended keeping blood sampling procedure handling storage and plasma preparation method constant in order to achieve highest reproducibility Plasma can be isolated according to protocols described in literature e g Chiu and Lo 2006 Birch et al 2005 or according to the following recommendation Preparation of plasma from human EDTA blood Centrifuge fresh blood sample for 10 min at 2 000 x 9 Remove the plasma without disturbing sedimented cells Freeze plasma at 20 C for storage upon DNA isolation A OD Thaw frozen plasma samples prior to DNA isolation and centrifuge for 3 min at 211 000 x g in order to remove residual cells cell debris and particulate matter Use the superna
15. f 30s larger plasma sample volumes have to be processed the loading step may be repeated Be aware of an increased risk of membrane clogging in case of multiple column loading steps If the solution has not completely passed the column centrifuge for an additional 60 s at 11 000 xg MACHEREY NAGEL 06 2014 Rev 04 17 NucleoSpin Plasma XS 5 Wash and dry silica membrane 1 wash 500 pL WB Pipette 500 uL Buffer WB onto the NucleoSpin 11 000 x g Plasma XS Column Centrifuge for 30s at 11 000 x g 30s Discard Collection Tube with flow through and place the column into new Collection Tube provided 2 wash 250 yL WB Add 250 uL Buffer WB to the NucleoSpin Plasma XS 11 000 x g Column Centrifuge for 3min at 11 000 x g Discard 3 im i Collection Tube with flow through and place the column into a 1 5 mL microcentrifuge tube for elution not provided 6 Elute DNA F 20 pL Add 20 uL Elution Buffer to the NucleoSpin Plasma XS Elution Buffer Column Centrifuge for 30 s at 11 000 x g Elution volume may be varied in range of 5 30 uL For a 11 correlation of elution volume DNA concentration and DNA 000 x g amount eluted from the column see section 2 4 30s 18 MACHEREY NAGEL 06 2014 Rev 04 Circulating DNA from plasma 6 Appendix 6 1 Troubleshooting Problem Possible cause and suggestions Low DNA content of the sample The content of cell free DNA in human plasma may vary o
16. hem 2004 Jun 50 6 1002 11 Epub 2004 Apr 8 Page K Powles T Slade MJ DE Bella MT Walker RA Coombes RC Shaw JA The Importance of Careful Blood Processing in Isolation of Cell Free DNA Ann N Y Acad Sci 2006 Sep 1075 313 317 Rainer TH Lam NY Man CY Chiu RW Woo KS Lo YM Plasma beta globin DNA as a prognostic marker in chest pain patients Clin Chim Acta 2006 Jun 368 1 2 110 3 Epub 2006 Feb 14 Rhodes A Wort SJ Thomas H Collinson P Bennett ED Plasma DNA concentration as a predictor of mortality and sepsis in critically ill patients Crit Care 2006 10 2 R60 Schmidt B Weickmann S Witt C Fleischhacker M Improved method for isolating cell free DNA Clin Chem 2005 Aug 51 8 1561 3 22 MACHEREY NAGEL 06 2014 Rev 04 Circulating DNA from plasma Sozzi G Roz L Conte D Mariani L Andriani F Verderio P Pastorino U Effects of prolonged storage of whole plasma or isolated plasma DNA on the results of circulating DNA quantification assays J Natl Cancer Inst 2005 Dec 21 97 24 1848 50 Wang M Block TM Steel L Brenner DE Su YH Preferential isolation of fragmented DNA enhances the detection of circulating mutated k ras DNA Clin Chem 2004 Jan 50 1 211 3 6 4 Product use restriction warranty NucleoSpin Plasma XS kit components are intended developed designed and sold FOR RESEARCH PURPOSES ONLY except however any other function of the product being expressly described in original MACHEREY N
17. material Up to 240 uL EDTA plasma single column loading Average yield Typically in a range of 0 1 100 ng per mL plasma depending on sample depending on kind of patient samples yield can be much higher Elution volume 5 30 uL Preparation time High sensitivity procedure 22 27 min 6 preps Rapid procedure 15 20 min 6 preps Format XS spin column DNA yield from human plasma DNA amounts from less than 0 1 ng DNA per mL of plasma up to several 100 ng DNA per mL of plasma have been reported Chiu et al 2006 Chun et al 2006 Fatouros et al 2006 Lazar et al 2006 Rainer et al 2006 Rhodes et al 2006 Schmidt et al 2005 The content of DNA in plasma depends on condition of the donor sampling and handling of the blood plasma preparation and DNA isolation method DNA quantification method and others Size of circulating DNA A good portion of the cell free DNA in plasma results from apoptotic cells Therefore a considerable percentage of this circulating nucleosomal DNA is known to be highly fragmented However the degree of fragmentation and the ratio of fragmented DNA to high molecular weight DNA depends on several parameters like origin ofthe DNA e g fetal tumor microbial DNA health of the blood donor blood sampling procedure and handling ofthe sample The performance of many downstream applications depends on the efficient isolation even of smallest DNA fragments Chan et al 2006 2005 2004 2003 Delig
18. ncrease signal output in PCR This is of importance especially if the template represents more than 20 of the total PCR reaction volume e g more than 4 uL eluate used as template in a PCR reaction with a total volume of 20 uL The template may represent up to 40 ofthe total PCR reaction volume ifthe eluate is incubated at increased temperature as described A volume of 20 uL used for elution will evaporate to 12 14 uL during a heat incubation for 8 min at 90 C If a higher final volume is required please increase the initial volume of elution buffer for example from 20 uL to 30 UL An incubation of the elution fraction for 8 min at 90 C will denature DNA If non denatured DNA is required e g for downstream applications other than PCR like ligation or cloning we recommend an incubation for longer time at a temperature below 80 C as most of the DNA has a melting point above 80 C Suggestion Incubate for 17 min at 75 C The incubation of the eluate at higher temperatures may be adjusted according to Figure 2 The incubation times and conditions shown will reduce an initial elution volume of 20 uL to about 12 14 uL and will effectively remove traces of ethanol as described above Ifthe initial volume of elution buffer applied to the column is less than 20 uL time of heat incubation should be reduced to avoid complete dryness The maximum percentage of template volume in a PCR reaction may vary depending on the
19. ng It is rather in the responsibility of the user or in any case of resale of the products in the responsibility of the reseller to inspect and assure the use of the DNA RNA protein purification products of MACHEREY NAGEL for a well defined and specific application MACHEREY NAGEL shall only be responsible for the product specifications and the performance range of MN products according to the specifications of in house quality control product documentation and marketing material MACHEREY NAGEL 06 2014 Rev 04 23 Circulating DNA from plasma This MACHEREY NAGEL product is shipped with documentation stating specifications and other technical information MACHEREY NAGEL warrants to meet the stated specifications MACHEREY NAGEL s sole obligation and the customer s sole remedy is limited to replacement of products free of charge in the event products fail to perform as warranted Supplementary reference is made to the general business terms and conditions of MACHEREY NAGEL which are printed on the price list Please contact us if you wish to get an extra copy There is no warranty for and MACHEREY NAGEL is not liable for damages or defects arising in shipping and handling transport insurance for customers excluded or out of accident or improper or abnormal use of this product defects in products or components not manufactured by MACHEREY NAGEL or damages resulting from such non MACHEREY NAGEL components or products MACHERE
20. ption 2 1 The basic principle 2 2 Kit specifications 2 3 Handling of sample material 2 4 Elution procedures 2 5 Removal of residual traces of ethanol for highest PCR sensitivity 2 6 Stability of isolated DNA 3 Storage conditions and preparation of working solutions 4 Safety instructions 5 Protocols 5 1 High sensitivity protocol for the isolation of DNA from plasma 5 2 Rapid protocol for the isolation of DNA from plasma 6 Appendix 6 1 Troubleshooting 6 2 Ordering information 6 3 References 6 4 Product use restriction warranty aan O 00 O 9 09 OD 11 12 14 14 17 19 19 20 20 23 MACHEREY NAGEL 06 2014 Rev 04 Circulating DNA from plasma 1 Components 1 1 Kit contents NucleoSpin Plasma XS 10 preps 50 preps 250 preps REF 740900 10 740900 50 740900 250 Binding Buffer BB 5 mL 22 mL 110 mL Wash Buffer WB 10 mL 50 mL 250 mL Elution Buffer 13 mL 13 mL 13 mL Proteinase K 6 mg 30 mg 2x75mg lyophilized Proteinase Buffer PB 1 8 mL 1 8 mL 8 mL NucleoSpin Plasma XS 10 50 250 Columns red rings plus Collection Tubes Collection Tubes 2 mL 20 100 500 User manual 1 1 1 Composition of Elution Buffer 5 mM Tris HCl pH 8 5 For preparation of working solutions and storage condistions see section 3 4 MACHEREY NAGEL 06 2014 Rev 04 Circulating DNA from plasma 1 2 Consumables and equipment to be supplied by user Consumables 1 5 mL microcentrifuge tube
21. regnant women Prenat Diagn 2005 Jul 25 7 604 7 Lam NY Rainer TH Chiu RW Lo YM EDTA is a better anticoagulant than heparin or citrate for delayed blood processing for plasma DNA analysis Clin Chem 2004 Jan 50 1 256 7 Lazar L Nagy B Ban Z Nagy GR Papp Z Presence of cell free fetal DNA in plasma of women with ectopic pregnancies Clin Chem 2006 Aug 52 8 1599 601 Epub 2006 Jun 1 Li Y Di Naro E Vitucci A Zimmermann B Holzgreve W Hahn S Detection of paternally inherited fetal point mutations for beta thalassemia using size fractionated cell free DNA in maternal plasma JAMA 2005 Feb 16 293 7 843 9 Erratum in JAMA 2005 Apr 13 293 14 1728 Li Y Holzgreve W DI Naro E Vitucci A Hahn S Cell free DNA in maternal plasma is it all a question of size Ann N Y Acad Sci 2006 Sep 1075 81 7 Li Y Holzgreve W Page Christiaens GC Gille JJ Hahn S Improved prenatal detection of a fetal point mutation for achondroplasia by the use of size fractionated circulatory DNA in maternal plasma case report Prenat Diagn 2004 Nov 24 11 896 8 Li Y Wenzel F Holzgreve W Hahn S Genotyping fetal paternally inherited SNPs by MALDI TOF MS using cell free fetal DNA in maternal plasma influence of size fractionation Electrophoresis 2006 Oct 27 19 3889 96 Li Y Zimmermann B Rusterholz C Kang A Holzgreve W Hahn S Size separation of circulatory DNAin maternal plasma permits ready detection of fetal DNA polymorphisms Clin C
22. s Disposable pipette tips Equipment e Manual pipettors Centrifuge for microcentrifuge tubes Vortex mixer Heating block for incubation at 90 C Personal protection equipment lab coat gloves goggles 1 3 About this user manual The manual provides two procedures differing in the number of handling steps speed and performance The High sensitivity procedure is recommended if highest DNA yield and concentration is required The Rapid procedure is recommended if shortest preparation time is required It is strongly recommended reading the detailed protocol sections of this user manual if the NucleoSpin Plasma XS kit is used for the first time Experienced users however may refer to the Protocol at a glance instead The Protocol at a glance is designed to be used only as a supplemental tool for quick referencing while performing the purification procedure All technical literature is available on the internet at www mn net com Please contact Technical Service regarding information about changes of the current user manual compared to previous revisions MACHEREY NAGEL 06 2014 Rev 04 5 Circulating DNA from plasma 2 Product description 2 1 The basic principle The NucleoSpin Plasma XS kit is designed for the efficient isolation of circulating DNA from human blood plasma Fragmented DNAas small as 50 1000 bp can be purified with high efficiency Due to a special funnel design the NucleoSpin Plasma XS Column
23. s allow very small elution volumes 5 30 uL which results in highly concentrated DNA The protocol follows state of the art bind wash elute procedures After mixing of a plasma sample with the binding buffer the mixture is applied to the NucleoSpin Plasma XS Column Upon loading of the mixture DNA binds to a silica membrane Two subsequent washing steps efficiently remove contaminations and highly pure DNA is finally eluted with 5 30 uL of a slightly alkaline elution buffer of low ionic strength 5 mM Tris HCl pH 8 5 2 2 Kit specifications The NucleoSpin Plasma XS kit is recommended for the isolation of fragmented cell free DNA from human EDTA plasma serum and bronchial lavage The NucleoSpin Plasma XS kit is designed for high recovery especially of fragmented DNA in a range of 50 1000 bp Up to 240 uL plasma can be used as sample material with a single column loading step DNA yield strongly depends on the individual sample but is typically in the range of 0 1 to 100 ng DNA per mL plasma Up to 720 uL plasma can be used with three column loadings Elution can be performed with as little as 5 30 uL elution buffer DNA is ready to use for downstream applications like real time PCR or others The preparation time is approximately 15 30 min for 6 12 plasma samples 6 MACHEREY NAGEL 06 2014 Rev 04 Circulating DNA from plasma Table 1 Kit specifications at a glance Parameter NucleoSpin Plasma XS Sample
24. tant for DNA isolation 2 4 Elution procedures The recommended standard elution volume is 20 uL A reduction of the elution volume to 5 15 uL will increase DNA concentration the total DNA yield is decreased by this reduction however An increase of the elution volume to 30 uL or more will only slightly increase total DNA yield but reduce DNA concentration Figure 1 gives a graphic description of the correlation between elution volume and DNA concentration to help finding the optimized elution volume for your individual application 054 _ gt 2 0 7 5 0 4 y D AH E ae 15 3 c s 03 S 2 5 10 gt oo 0 24 c e u O14 0 5 20 uL 10 uL 5 ul cae Decreasing elution volume Figure 1 Correlation between elution volume and DNA concentration NucleoSpin Plasma XS Columns 8 MACHEREY NAGEL 06 2014 Rev 04 Circulating DNA from plasma 2 5 Removal of residual traces of ethanol for highest PCR sensitivity A reduction of the 20 uL standard elution volume will increase the concentration of residual ethanol in the eluate For 20 uL elution volume a heat incubation of the elution fraction incubate eluate with open lid for 8 min at 90 C is recommended if the eluate comprises more than 20 of the final PCR volume in order to avoid an inhibition of sensitive downstream reactions In this context please mind the remarks below An incubation of the elution fraction at higher temperatures will i
25. ucleoSpin Plasma XS Removal of residual ethanol Incubate elution fraction with open lid for 8 min at 90 C 90 C min See section 2 5 for further comments and alternative 8 incubation times and temperatures for a removal of residual ethanol 16 MACHEREY NAGEL 06 2014 Rev 04 NucleoSpin Plasma XS 5 2 Rapid protocol for the isolation of DNA from plasma The rapid procedure represents a good compromise between DNA yield and concentration as well as ease and speed of nucleic acid extraction 1 Prepare sample Add 200 pL plasma to a microcentrifuge tube not 200 uL provided plasma Less than 240 uL may be used Adopt the binding buffer volume accordingly see below 2 Adjust DNA binding conditions Add 300 uL Buffer BB 300 pL BB If less than 200 uL plasma is used adjust the binding buffer volume accordingly A ratio of 1 1 5 v v for plasma and binding buffer has to be ensured 3 Mix sample Mi l Invert the tube 3x and vortex for 3 s Centrifuge the tube E Sampie briefly to clean the lid 4 Bind DNA For each sample load the mixture 500 pL to a NucleoSpin Plasma XS Column placed in a Collection Tube 2 mL a Centrifuge at 11 000 x g for 30 s Discard Collection Tube Load lysate with flow through and place column into new Collection Tube provided The maximal column volume is approximately 600 uL amp S 11 000 x g Do not apply a higher volume in order to avoid spillage I
26. ver several orders of magnitude DNA contents from approximately 0 1 1000 ng DNA per mL of plasma have been reported see remarks in section 2 2 Low DNA yield If the DNA concentration is measured with double strand specific dyes e g PicoGreen and step 7 Removal of residual ethanol with incubation at 90 C is performed the measured yield is below the actual value This is due to the denaturation of DNA during the heat incubation step and the double strand specificity of certain DNA dyes e g PicoGreen Sample contains residual cell debris or cells The plasma sample may have contained residual cells or cell debris Make sure to use only clear plasma samples see remarks in section 2 3 Column clogging No increase Residual ethanol in eluate of PCR signal Please see the detailed description of removal of residual despite of an traces of ethanol in section 2 5 increased volume of eluate used as template in PCR MACHEREY NAGEL 06 2014 Rev 04 19 Circulating DNA from plasma Silica abrasion from the membrane Due to the typically low DNA content in plasma and the resulting low total amount of isolated DNA a DNA quantification via A absorption measurement is often Discrepancy hampered due to the low sensitivity of the absorption between A measurement When performing absorption measurements quantification close to the detection limit of the photometer the values and PCR measurement
27. zeichnet werden Component Hazard contents GHS symbol Hazard Precaution phrases phrases Inhalt Gefahrstoff GHS Symbol H S tze P S tze BB Guanidinium thiocya Warning 226 302 210 233 260D nate 30 60 ethanol 412 273 301 312 330 35 55 EUH031 403 235 Guanidiniumthiocyanat Achtung 30 60 Ethanol 35 55 WB Ethanol 55 75 Warning 225 210 233 403 235 Ethanol 55 75 Achtung Proteinase K Proteinase K lyophilized Danger 315 317 261 280 302 352 Proteinase K lyophilisiert Gefahr 319 334 304 340 335 305 351 338 312 D 332 313 337 313 342 311 363 403 233 Hazard phrases H 225 Highly flammable liquid and vapour Fl ssigkeit und Dampf leicht entz ndbar H 226 Flammable liquid and vapour Fl ssigkeit und Dampf entz ndbar H 302 Harmful if swallowed Gesundheitssch dlich bei Verschlucken H 315 Causes skin irritation Verursacht Hautreizungen H 317 May cause an allergic skin reaction Kann allergische Hautreaktionen verursachen H 319 Causes serious eye irritation Verursacht schwere Augenreizung H 334 May cause allergy or asthma symptoms or breathing difficulties if inhaled Kann bei Einatmen Allergie asthmaartige Symptome oder Atembeschwerden verursachen H 335 May cause respiratory irritation 12 MACHEREY NAGEL 06 2014 Rev 04 Circulating DNA from plasma Hazard phrases H 412 EUH031 Kann die Atemwege reizen Harmful to aquatic life with long lasting
Download Pdf Manuals
Related Search